TRAIL resistance results in cancer progression: a TRAIL to perdition? (Q53616910)

16 May 2018

title

TRAIL resistance results in cancer progression: a TRAIL to perdition? (English)

1 reference

16 May 2018

author name string

Malhi H

series ordinal

1 reference

16 May 2018

Gores GJ

series ordinal

1 reference

16 May 2018

language of work or name

English

0 references

publication date

19 June 2006

1 reference

16 May 2018

published in

Oncogene

1 reference

16 May 2018

volume

1 reference

16 May 2018

issue

1 reference

16 May 2018

page(s)

7333-7335

1 reference

16 May 2018

Apoptosis control by death and decoy receptors

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209765

7 January 2021

Pancreatic cancer biology and genetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209765

7 January 2021

cFLIP regulation of lymphocyte activation and development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209765

7 January 2021

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209765

7 January 2021

Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209765

7 January 2021

An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209765

7 January 2021

Following a TRAIL: update on a ligand and its five receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209765

7 January 2021

Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209765

7 January 2021

Cellular FLICE/caspase-8-inhibitory protein as a principal regulator of cell death and survival in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209765

7 January 2021

Does CD95 have tumor promoting activities?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209765

7 January 2021

Combining proteasome inhibition with TNF-related apoptosis-inducing ligand (Apo2L/TRAIL) for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209765

7 January 2021

Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209765

7 January 2021

Temperature-sensitive differential affinity of TRAIL for its receptors. DR5 is the highest affinity receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209765

7 January 2021

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209765

7 January 2021

Mechanisms of resistance to TRAIL-induced apoptosis in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209765

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209765

1 reference

16 May 2018

1 reference

16 May 2018